The effect ofsystemic stero idadministration on intraocular pressure (l OP) is well established. However; less attention has been paid to the effect of steroids when administered in a nasal spray. We conducted a study to investigate a possible association between nasal steroids and elevated lOP in 54 patients who were being treated f or allergic rhinitis. lOP was measured before the patients started therapy and thereaft er every 5 days du ring that therapy.
Introduction
It is well known that steroids can cause an ele vation of intrao cular pre ssure (lOP), whether they are administered topi cally as skin cream s' or ophthalmic drop s, or when they are administered sys temically for a long time. t-' For instance, topic al ocul ar adm inistrati on of a potent steroid for 4 to 6 weeks can produce an ele vated lOP in approximately 40 % of the general population ." The increase in lOP occur s more frequently in patient s with chronic simple glaucoma or in tho se with a fam ily history of this disease.'
Howe ver, only a few studies have reported the effect of steroids on lOP when administered in nasal sprays.>?The purpose of this study is to measure lOP after the nasal adm inistration of steroids. 
Patients and methods
Fifty -four patients-36 women and 18 men , aged 22 to 55 yea rs (mea n: 47)-who were examined in an outpatient setting at our institution were included in this study. All thes e patients had allergic rhinitis and were receiving nasal steroids for its treatment.
Patients were excluded from this study if they (1) had an ophthalmic disease or any systemic illness other than allergy, (2) were receiving any drugs topically or systemically other than nasal steroids, or (3) had reported any previous corticosteroid use. Patients who were not compliant with the treatment regimen or the lOP measuring program were dropped from the study.
Before therapy was initiated, a detailed per sonal, ophthalmic, and family history was obtained for each patient, and each underwent a full ophthalmic examination that included the mea surement of lOP, checking of the angle of the anterior chamber, and direct ophthalmo scopy to define the concavity of the optic disc.
After therapy wa s initiated, lOP was mea sured every 5 days as long as no ele vation of this pressure was noted and every 2 days when ele vation was observed. lOP measurement was done with an appl anat ion tonometer every morning to exclude accidental findings caused by the normal dail y fluctuation of lOP. Follow-up ran ged from 27 to 35 days (me an: 31).
The results ofsuccessive measurements were registered; sub sequ ently, the observed lOP differences were statistically analyzed. The stati stical analysis of the results was done using the paired Student's t-test.
All patients in the study were given an aerosol formul ation containing a combination oftramazoline hydrochloride ( 120 ug) and dexamethasone (20 ug), administered as a nasal spray at a dos age of 1 spray in each nostril once daily.
Results
Before patients started therapy, their lOPs ranged from 10 to 15 mm Hg .Thirty-six ofthe 54 patients (66 .7%) showed no change, 6 (11.1 %) had a 1-mm Hg increase,S (9.3 %) had a 2-mm Hg increase, and 3 (5.6%) had a 3-mm Hg increase; only 4 patients (7.4%) had an ele vation of4 mrn Hg. Despite these increases, all patients' lOPs rem ained within normal limits. Statistical analysis showed that the differences were not statistically significa nt (p > 0.1).
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Discussion
Steroids administered in the form of nasal sprays are indicated mainly for the treatment of seasonal and perennial allergic rhinitis, but they are also given to many pat ient s with bronchial asthma. Before this study , only a few reports correlated the administration of nas al steroid sprays with the formation ofposterior cap sular cataracts and glaucoma. However, it has been proven that the system ic absorption of steroids given as nas al sprays reaches or exceeds 50%10; therefore, potential ophthalm ic side effects should be expected and examined.
In 1990, Fraunfelder and Meyer were the first inve stigators to correlate the administration of beclomethasone nasal sprays with bilateral posterior capsular cataracts. II Most of the 21 patients with cat aract s in their study had used that medication longer than 5 years , and 9 patients had received steroids systemically. In 1993, Simons et al did not observe cataracts in young patients who were successfully treated with inhaled steroids."
Reports in the literature of lOP respon se to the administration of nasal steroids are conflicting. The first study to examine the relationship between inha led or nasal steroid sprays and IOPwas published in 1993 by Dreyer, reporting on 3 patients who presented with glaucoma after the administration of beclomethasone inhalation spray.' Two years later, Opatowsky et al described 3 patients with increased lOP that probably was related to beclomethasone nasal spray or inhalation." Two of tho se patients had diabetes mellitus and the third had asthma, which neces sitated the administration of steroids by mouth . In all 3 cases, the lOP returned to norm al after the elimination of steroids.
In agreement with tho se reports, Bui et al showed some years later that discontinuing nasal steroids might lower lOP in eyes with glaucoma,' suggesting that nasal steroids might contribute to lOP increase. Yet Garbe et al reported that only patients receiving high do ses of inhaled or nasal steroids for 3 or more months were at increased risk for ocular hypertension or open-angle glaucoma." However, in a large, prospective, controlled study of360 patients using placebo or one of three different nasal topic al steroids for 1 year, Bros s-Soriano et al showed that the observed variations in lOP were within normal limits ." Evidently, more data are needed to confirm or contradict the above conflicting reports.
A review of the literature re veal s that our 54 patients compose one of the largest groups in whom the correlation of the administration of nasal steroid sprays with increased lOP has been studied to date . It is also the first time that the combination of tram azoline and dexamethasone was correlated with lOP.
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Our result s demonstrate no statistically signific ant increase in lOP after the short-term administration of tramazoline/dexamethasone nasal spray. We believe, therefore, that the combination of tramazoline and dexamet hasone, administered for a short time for the treatment of nasal allergy, is safe in terms of its effect on lOP.
It is likely that the side effects of the absorbed steroids depend not only on the type of steroid given, but also on the duration of administration. Therefore, further research is needed to determine the possible relationship between steroids and lOP when administered over a long period. Until that relationship has been establi shed , we recommend that lOP and the condition of the optic nerve be observed during long-term administration of nasal steroids.
